Holen Sie sich die Stockscreener-App
1.37
2.84%
-0.04
Handel nachbörslich:
1.39
0.02
+1.46%
Schlusskurs vom Vortag:
$1.41
Offen:
$1.48
24-Stunden-Volumen:
23,371
Relative Volume:
0.01
Marktkapitalisierung:
$26.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.08%
1M Leistung:
-29.74%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.37
$1.48
1-Wochen-Bereich:
$1.31
$1.48
52-Wochen-Spanne:
$1.25
$6.95
Osr Holdings Inc Stock (OSRH) Company Profile
Firmenname
Osr Holdings Inc
Sektor
Branche
Telefon
425-635-7700
Adresse
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Vergleichen Sie OSRH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSRH
Osr Holdings Inc
|
1.37 | 26.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Osr Holdings Inc Aktie (OSRH) Neueste Nachrichten
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - Nasdaq
OSR Holdings Inc’s Market Journey: Closing Weak at 1.53, Down -21.54 - DWinneX
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology - digitalmore.co
Game-Changing Osteoarthritis Drug Patent: AI-Enhanced Protein Treatment Targets $16B Market - Stock Titan
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
OSR Holdings (OSRH) Sees Strong Pre-Market Gains - Stocks Telegraph
OSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation Fund - MSN
OSR Holdings Signs $80 Million Stock Deal to Support Brain Cancer Research: Shares Up - marketscreener.com
OSR Signs $80 Mln Stock Purchase Agreement With White Lion GBM Innovation Fund, Stock Up - Nasdaq
OSR Holdings secures $80 million funding option for cancer therapy - Investing.com
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies - digitalmore.co
OSR Holdings Delays Annual Report Filing - TipRanks
Best Biotech Stocks To Follow Today – March 26th - Defense World
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
OSR Holdings (OSRH) Sees Stock Surge After Positive Trial Results - Stocks Telegraph
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma - The Malaysian Reserve
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
Sector Update: Health Care - Marketscreener.com
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump - MarketScreener
Breakthrough in Brain Cancer Treatment: New Trial Data Reveals 11.1-Month Survival Rate - Stock Titan
OSR Holdings names new chief scientific officer By Investing.com - Investing.com South Africa
Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc. - The Victoria Advocate
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer | DigitalMore.co - digitalmore.co
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - Marketscreener.com
OSR Holdings names new chief scientific officer - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
OSRH Stock Plummets to 52-Week Low at $1.31 Amid Market Challenges - Investing.com Canada
OSRH Stock Plummets to 52-Week Low at $1.31 Amid Market Challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bellevue Life Sciences Acquisition Corp. Announces Approval of B - GuruFocus.com
OSR Holdings announces $80 million equity agreement with White Lion By Investing.com - Investing.com South Africa
OSR Holdings announces $80 million equity agreement with White Lion - Investing.com
OSR Holdings Ends Shell Status with Share Issuance - TipRanks
Stock market news: MicroAlgo +577.70%, OSR Holdings +46.38% among top gainers during midday trading - Business Upturn
Stock market news: MicroAlgo skyrocketed by 480.87% whereas Mobile-health Network plunged by 42.65% during midday trading - Business Upturn
Stock market today: MicroAlgo +213.92%, GDEV +34.08% among top gainers in early trading - Business Upturn
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - NewsBreak
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
OSRH Stock Price and Chart — NASDAQ:OSRH - TradingView
Bellevue Life Sciences Acquisition Corp. will Change its Name to OSR Holdings, Inc - marketscreener.com
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.3 million in funding - Marketscreener.com
Stock market today: Asian benchmarks trade mostly higher as investors continue to eye Trump - 69News WFMZ-TV
Japan's economy grows more than expected on strong exports and moderate consumption - 69News WFMZ-TV
US presented Ukraine with a document to access its minerals but offered almost nothing in return - 69News WFMZ-TV
Argentine lawyers charge President Milei with fraud over cryptocurrency promotion - 69News WFMZ-TV
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.37% - Investing.com India
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic' - Benzinga India
Major Business Combination: OSR Holdings Takes Over BLAC, Debuts on Nasdaq Next Week - Stock Titan
Finanzdaten der Osr Holdings Inc-Aktie (OSRH)
Es liegen keine Finanzdaten für Osr Holdings Inc (OSRH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):